✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Novo Nordisk A/S

Common Name
Novo Nordisk
Country
Denmark
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
67,900
Ticker
NOVO B
Exchange
Nasdaq Copenhagen
Description
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabe...

Novo Nordisk's Board and Committee Meetings Data

Explore Novo Nordisk's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2025
Board Meeting Count
19a
Board Meeting Attendance Rate
99.56%b
Audit Committee Meeting Count
5a
Audit Committee Meeting Attendance Rate
100%b
Compensation/Remuneration Committee Meeting Count
6a
Compensation/Remuneration Committee Meeting Attendance Rate
100%b
Nomination Committee Meeting Count
3a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Novo Nordisk’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Novo Nordisk's Corporate Governance Report 2025
b. Novo Nordisk's Annual Report 2025